A Study of Infacort® Versus Cortef® in Healthy Adult Male and Female Subjects
Status:
Completed
Trial end date:
2018-07-13
Target enrollment:
Participant gender:
Summary
This was a two-part, single centre, open-label, randomised, single dose, two-period,
crossover study to evaluate the bioavailability of Infacort® versus Cortef® immediate release
hydrocortisone tablets in dexamethasone-suppressed healthy adult male and female subjects in
the fasted and fed states.
Phase:
Phase 1
Details
Lead Sponsor:
Diurnal Limited
Collaborators:
Bionical-Emas Pharma Ltd Brush Clinical Research Ltd. Emas Pharma Ltd. Medical Matters International Ltd. Nichol Pharma Services Ltd. Simbec Research Voet Consulting